Countdown to Abbott (ABT) Q2 Earnings: A Look at Estimates Beyond Revenue and EPSZacks Investment Research • 07/14/25
Abbott (ABT) Suffers a Larger Drop Than the General Market: Key InsightsZacks Investment Research • 07/11/25
Abbott (ABT) Earnings Expected to Grow: What to Know Ahead of Next Week's ReleaseZacks Investment Research • 07/10/25
ABT's FreeStyle Libre 3 Plus Now Available in Canada: Stock to Rise?Zacks Investment Research • 07/10/25
Abbott Sees Upside on Diagnostics Growth, FreeStyle Libre ExpansionZacks Investment Research • 07/02/25
Abbott Laboratories: FreeStyle Libre CGMs And EPD Business Driving Positive MomentumSeeking Alpha • 06/30/25
Should You Continue to Retain Abbott Stock in Your Portfolio Now?Zacks Investment Research • 06/24/25
New Research on Abbott's Healthy Food Rx Program Shows 'Food is Medicine' Approach Helps People Living With Diabetes Eat Better and Feel HealthierPRNewsWire • 06/20/25
ABT's i-STAT TBI Test Receives Approval in Canada: Stock to Rise?Zacks Investment Research • 06/19/25
5 Dividend Kings Are Delivering Massive Total Returns of Up to 34% This Year24/7 Wall Street • 06/13/25
Healthcare companies are hiring. Is it time to look for growth stocks in this beaten-down sector?Market Watch • 06/06/25